2023
Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure
Mentz R, Anstrom K, Eisenstein E, Sapp S, Greene S, Morgan S, Testani J, Harrington A, Sachdev V, Ketema F, Kim D, Desvigne-Nickens P, Pitt B, Velazquez E, Adams K, Bhatt K, DeWald T, Axsom K, Murthy S, Rich J, Testani J, Smith B, Vader J, McCulloch M, Skopicki H, Psotka M, Heroux A, Lala-Trindade A, Stevens G, Tang W, Lev Y, William P, Eberly A, Gottleib S, Haught W, Grafton G, Larned J, Tejwani L, Mody F, Krim S, Robinson M, Fang J, Adler A, Bell A, Banerjee D, Ruiz Duque E, Mizyed A, Rommel J, Arhinful J, Goyal P, Hall M, Hummel S, Shetty S, Haas D, Vilaro J, Alexy T, Herre J, Clark J, Ambrosy A, Gaglianello N, Ramasubbu K, Meadows J, Tabtabai S, Sherwood M, Hasni S, D'Urso M, Muneer B, Dunlap S, Davis W, Friedman D, Guglin M, Ferguson A, Abbate A, Smart F. Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure. JAMA 2023, 329: 214-223. PMID: 36648467, PMCID: PMC9857435, DOI: 10.1001/jama.2022.23924.Peer-Reviewed Original ResearchConceptsCause mortalityHeart failureTorsemide groupFurosemide groupTotal hospitalizationsCause hospitalizationEffects of torsemideDiuretic strategyPrespecified subgroupsSecondary outcomesEjection fractionMedian agePrimary outcomeHospitalizationMAIN OUTCOMEPatientsFurosemideMortalityMonthsTorsemidePrimary hypothesisSignificant differencesFinal dateOutcomesTrials
2019
Clinical Overlap Between Myopericarditis and Stress Induced Cardiomyopathy: A Diagnostic and Therapeutic Challenge
Sharma T, Tigadi S, Baldwin J, Tabtabai S. Clinical Overlap Between Myopericarditis and Stress Induced Cardiomyopathy: A Diagnostic and Therapeutic Challenge. American Journal Of Case Reports 2019, 20: 252-257. PMID: 30804319, PMCID: PMC6402271, DOI: 10.12659/ajcr.912169.Peer-Reviewed Original ResearchConceptsErythrocyte sedimentation rateEjection fractionApical ballooningPR depressionHistory of emotional stressElevated erythrocyte sedimentation rateNon-obstructive coronary diseaseNon-obstructive coronary arteriesDiagnosis of myopericarditisPleuritic chest painVentricular apical ballooningReduced ejection fractionT-wave inversionType of therapyFlu-like illnessSecondary to extensionNext 2 daysMasquerading presentationPleuritic painViral prodromeAcute myopericarditisChest painAtypical presentationMyocardial inflammationElectrocardiogram findings
2017
Acoustic speech analysis of patients with decompensated heart failure: A pilot study
Murton O, Hillman R, Mehta D, Semigran M, Daher M, Cunningham T, Verkouw K, Tabtabai S, Steiner J, Dec G, Ausiello D. Acoustic speech analysis of patients with decompensated heart failure: A pilot study. The Journal Of The Acoustical Society Of America 2017, 142: el401-el407. PMID: 29092550, PMCID: PMC5724620, DOI: 10.1121/1.5007092.Peer-Reviewed Original ResearchConceptsHeart failureIntracardiac filling pressuresDecompensated heart failureSpeech analysisIndicators of HFAcoustic speech analysisSpeech breathing characteristicsDiuretic treatmentPeripheral edemaPilot studyFilling pressureCreaky voiceSpeech passagesPatientsMonitoring patientsSpeech respirationSpeechIncreasing fundamental frequencyEdemaSustained vowelsAcoustic measurements
2016
National Trends in Hospitalizations of Adults With Tetralogy of Fallot
Schmidt A, Yeh D, Tabtabai S, Kennedy K, Yeh R, Bhatt A. National Trends in Hospitalizations of Adults With Tetralogy of Fallot. The American Journal Of Cardiology 2016, 118: 906-911. PMID: 27530825, PMCID: PMC5349299, DOI: 10.1016/j.amjcard.2016.06.034.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultArrhythmias, CardiacComorbidityCross-Sectional StudiesDatabases, FactualDiabetes MellitusEquipment FailureFemaleHeart FailureHeart Valve Prosthesis ImplantationHospital CostsHospital MortalityHospitalizationHumansHypertensionKidney DiseasesMaleMiddle AgedObesityPneumoniaPrevalencePulmonary ValveTetralogy of FallotUnited StatesYoung AdultConceptsTetralogy of FallotHigher quality of careCo-morbiditiesQuality of careFollow-up of patientsHealth care systemPrevalence of obesityModifiable risk factorsPrevalence of co-morbiditiesRates of co-morbiditiesUnited States Nationwide Inpatient SamplePulmonic valve replacementPrimary admission diagnosisHospitalizations of adultsPopulation of adultsNationwide Inpatient SampleCross-sectional dataCare systemDiagnostic codesValve replacementPrevention effortsHeart failureHospital admissionAdmission diagnosisFollow-up
2015
Assessing mitral regurgitation in the prediction of clinical outcome after cardiac resynchronization therapy
Upadhyay G, Chatterjee N, Kandala J, Friedman D, Park M, Tabtabai S, Hung J, Singh J. Assessing mitral regurgitation in the prediction of clinical outcome after cardiac resynchronization therapy. Heart Rhythm 2015, 12: 1201-1208. PMID: 25708879, DOI: 10.1016/j.hrthm.2015.02.022.Peer-Reviewed Original ResearchConceptsCardiac resynchronization therapyDegree of baseline MRMitral regurgitationBaseline MRMR improvementHF hospitalizationClinical outcomesSurface QRSHeart failureAssociated with lower HF hospitalizationsCohort study of patientsImproved ventricular geometryFollow-up echocardiographyPrediction of clinical outcomeReducing mitral regurgitationStudy of patientsAll-cause mortalityPrediction of HFWorsening MRMR severityMedian ageIschemic cardiomyopathyResynchronization therapyImproved survivalMR reduction